April 17, 2014 6:25 AM ET

Pharmaceuticals

Company Overview of MabVax Therapeutics, Inc.

Executive Profile

Philip Livingston M.D.

Chief Science Officer and Director, MabVax Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 5 different industries.

See Board Relationships
----

Background

Prof. Philip O. Livingston, M.D. serves as Chief Science Officer of MabVax Therapeutics Inc. Dr. Livingston serves as the Head of the Laboratory of Tumor Vaccinology at MSKCC where he has treated cancer patients and conducted research for over 30 years. He is a Co-Founder of Adjuvance Technologies, Inc. Dr. Livingston serves as Member of Scientific Advisory Board of Optimer Pharmaceuticals, Inc. He serves as a Member of the Cancer Scientific Advisory Board of Progenics ...

Corporate Headquarters

11588 Sorrento Valley Road
San Diego, California 92121

United States

Phone: 858-259-9405
Fax: --

Board Members Memberships

Chief Science Officer and Director

Education

Unknown/Other Education
Princeton University
Unknown/Other Education
Harvard Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MabVax Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.